UK Biobank Cohort Data on Metabolic Syndrome and Stroke Risk

UK Biobank data from a prospective cohort study of 329,887 participants free of stroke at baseline. The dataset, authored by Yan Zhou and last updated in 2026, examines associations between metabolic syndrome components and incident stroke over a median follow-up of 14.1 years.

Use Cases

• Modeling stroke risk based on the number of metabolic syndrome components present.
• Analyzing the association between elevated blood pressure and incident stroke.
• Comparing hazard ratios for ischemic versus hemorrhagic stroke linked to metabolic syndrome.
• Investigating the individual contribution of metabolic syndrome components (e.g., waist circumference, triglycerides) to cardiovascular outcomes.

Strengths

• Large cohort size of 329,887 participants.
• Longitudinal design with a median follow-up period of 14.1 years.
• Clear outcome definition using hospital records, death registries, and self-reported data.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to the UK Biobank population.

Provenance

Source

UK Biobank

Collection Method

Population-based prospective cohort study.

Time Range

Median follow-up of 14.1 years.

Freshness

Last updated 2026-04-14 13:12:29; freshness should be verified.

Geography

United Kingdom